Literature DB >> 21523396

Cell and gene therapy for bone repair.

P J Marie1.   

Abstract

Improving bone repair remains an important and challenging issue. Therapeutic approaches to amplify osteogenic cell pool or function include cell and gene therapies. We identified genes that promote human mesenchymal cell differentiation and bone formation. Targeting these or other genes may improve the efficacy of cell therapy for bone repair.

Entities:  

Mesh:

Year:  2011        PMID: 21523396     DOI: 10.1007/s00198-011-1615-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  20 in total

1.  Tissue-engineered bone regeneration.

Authors:  H Petite; V Viateau; W Bensaïd; A Meunier; C de Pollak; M Bourguignon; K Oudina; L Sedel; G Guillemin
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

2.  Treatment of osteonecrosis with autologous bone marrow grafting.

Authors:  Philippe Hernigou; Françoise Beaujean
Journal:  Clin Orthop Relat Res       Date:  2002-12       Impact factor: 4.176

Review 3.  Protein- and gene-based tissue engineering in bone repair.

Authors:  Michelle D Kofron; Xudong Li; Cato T Laurencin
Journal:  Curr Opin Biotechnol       Date:  2004-10       Impact factor: 9.740

Review 4.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 5.  Mesenchymal stem cells in bone and cartilage repair: current status.

Authors:  Jean-Thomas Vilquin; Philippe Rosset
Journal:  Regen Med       Date:  2006-07       Impact factor: 3.806

6.  Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach.

Authors:  Ehsan Jabbarzadeh; Trevor Starnes; Yusuf M Khan; Tao Jiang; Anthony J Wirtel; Meng Deng; Qing Lv; Lakshmi S Nair; Steven B Doty; Cato T Laurencin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

Review 7.  Circulating endothelial/skeletal progenitor cells for bone regeneration and healing.

Authors:  Tomoyuki Matsumoto; Ryosuke Kuroda; Yutaka Mifune; Atsuhiko Kawamoto; Taro Shoji; Masahiko Miwa; Takayuki Asahara; Masahiro Kurosaka
Journal:  Bone       Date:  2008-05-10       Impact factor: 4.398

8.  Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.

Authors:  Panagiota A Sotiropoulou; Sonia A Perez; Maria Salagianni; Constantin N Baxevanis; Michael Papamichail
Journal:  Stem Cells       Date:  2005-08-18       Impact factor: 6.277

Review 9.  Human mesenchymal stem cells: from basic biology to clinical applications.

Authors:  B M Abdallah; M Kassem
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

10.  Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis.

Authors:  Zahia Hamidouche; Olivia Fromigué; Jochen Ringe; Thomas Häupl; Pascal Vaudin; Jean-Christophe Pagès; Samer Srouji; Erella Livne; Pierre J Marie
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

View more
  3 in total

Review 1.  Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts.

Authors:  Maya Fakhry; Eva Hamade; Bassam Badran; René Buchet; David Magne
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 2.  The Utility of Allograft Mesenchymal Stem Cells for Spine Fusion: A Literature Review.

Authors:  Daniel Lubelski; Kalil G Abdullah; Edward C Benzel; Thomas E Mroz
Journal:  Global Spine J       Date:  2012-06

3.  Effect of cyclic mechanical stimulation on the expression of osteogenesis genes in human intraoral mesenchymal stromal and progenitor cells.

Authors:  Birgit Lohberger; Heike Kaltenegger; Nicole Stuendl; Michael Payer; Beate Rinner; Andreas Leithner
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.